
How Often You Really Need to Replace Your Contact Lenses, and What Happens When They Expire
It wasn't until almost 1950 that the first modern plastic contact lens were introduced, and disposable contact lenses wouldn't hit the market until the '80s. As Dr. Robert Kinast puts it, "We think of contact lenses as being so normal, but 100 years ago, nobody walked around with little pieces of plastic over their eyes."
Kinast, the vice chair of ophthalmology at Legacy Devers Eye Institute and co-founder of GentleDrop, says, "Contact lenses are foreign bodies and should be treated with respect." To that end, we talked with eye experts to learn how to care for contact lenses and when to replace them.
How long do contacts last?
The lifespan of your contact lenses depends on a few factors. Dr. Meenal Agarwal, optometrist and podcast host, explains, "Soft daily disposables are single-use, so you need to discard them after one day." At the other end of the spectrum, she says that "hard lenses can last one to two years with proper care." The most important rule, Agarwal says, is to always follow the replacement schedule recommended by your eye doctor.
Soft lenses are the most commonly worn contact lenses, according to Dr. Jovi Boparai, ophthalmic surgeon and co-founder and CEO of CorneaCare. He explains that these lenses "range from daily disposables to weekly, biweekly or monthly." However, "Rigid gas permeable contact lenses can last much longer, ranging from months to a year." These lenses are made of hard plastic.
While most contact lenses will last for the intended duration, some factors may shorten their lifespan. For instance, dust and smoke may cling to your lenses and make them unusable. If there is a wildfire in your area or a high allergen count and your lenses start to feel uncomfortable, you may want to toss them early.
How to know if your contacts are expired
The quickest way to gauge whether your contacts are expired is to look at the date on the box. Boarpai says that unopened contact lenses generally have a shelf life of one to four years from the date of manufacturing.
Beyond reviewing the expiration date, you should pay attention to how your lenses look. According to Dr. Boparai, old lenses may show discoloration or damage. He also warns that expired contacts can develop deposits -- meaning a buildup of residue on the lenses.
On the other hand, your contacts may still be expired, even if they look great. Agarwal warns, "The lenses may look the same as they did on the first day, but that doesn't mean they're still safe to use." In short, you should defer to the expiration date first, but also ditch your lenses if there is obvious damage or they become painful.
Anna Gragert/CNET
Expired contact lens symptoms
It's easy to lose track of your lens-changing schedule when life gets busy. If that happens, your lenses may let you know they're expired before you even have a chance to track down the date on the box.
"Wearing expired contacts can cause redness, pain or discomfort, irritation, blurry vision, excessive dryness and/or infections," Agarwal warns. You should take these symptoms as a red flag. The doctor advises, "If you experience any of these symptoms, remove the lenses and consult your eye doctor."
According to Boparai, additional symptoms may include "burning, watery eyes, light sensitivity, discharge, foreign body sensation and eyelid swelling."
Signs that your contacts are ready to be replaced
It's worth noting that you won't always experience symptoms when your contacts are ready to be changed. Sticking to the appropriate schedule is vital, even if you think your contacts could last a few more weeks. As Agarwal explains, "Most of the time, you will not have any symptoms when your lenses are ready to be replaced."
However, the doctor reiterates that if you've overworn contacts for a long time, you may notice vision problems, painful symptoms or "a torn or damaged lens and/or a buildup of deposits or debris on the lenses." This means it's definitely time to switch to a fresh pair.
How often should I change my contact lenses?
The simplest answer is to follow the recommended duration of use. Boparai reiterates that you should change lenses based on "the lifespan of the contact lenses as recommended by your eye doctor."
You may also want to consider the length of time you're wearing your lenses per day. According to Optometrists Network, about half of all contact lens wearers don't comply with the wear schedule recommended by their doctors. This can lead to something called contact lens overwear syndrome, which occurs when your lenses obstruct your eyes' ability to absorb oxygen. Left untreated, you may experience bloodshot eyes, infection or a damaged cornea.
Both doctors we spoke to insisted that you should never sleep in contacts unless it's recommended by a doctor. This may help prevent overwear syndrome and lower your risk of infections and ulcers. It also gives you an incentive to check your lenses each morning to make sure it's not time to change them out.How to care for your contact lenses
Proper care for your contacts not only helps maximize their lifetime but may also prevent eye infections. First and foremost, you should always handle your contact lenses with clean hands, according to the American Academy of Ophthalmology. The organization also recommends using a "rub and rinse" method each time you use your lenses. This means you should first rub your lens with clean fingers and then rinse it with a contact lens solution.
Contact lenses carry an increased risk of eye inflammation and infection, Boparai says. He adds that proper contact lens hygiene includes rinsing the lenses for 10 to 20 seconds before wear and making sure you don't touch your cornea when adding or removing the lenses. Boparai also recommends changing your contact lens solution every day.
Meenal emphasizes the importance of storing your lenses "in a clean case and replacing the case every three months." She warns that you should never use water or saliva to clean your contact lenses.
How to prevent contact lens-related eye infections
The most common eye infection associated with contact lenses is keratitis, which the Mayo Clinic describes as an inflammation of the cornea. And this infection happens a lot. The US Centers for Disease Control and Prevention analyzed contact lens-related infections between 2005 and 2015 and determined that "keratitis from all causes, including contact lens wear, results in approximately 1 million clinic and emergency department visits annually."
The AAO says that wearing extended-wear lenses, sleeping in your lenses and keeping a dirty lens case can all make you vulnerable to this type of infection. The Mayo Clinic warns that poor contact lens hygiene allows for the growth of bacteria, fungi and parasites that can infect your cornea.
Agarwal adds to this advice, explaining that contact lens wearers should never share or reuse lenses. She also warns that you should "avoid wearing contacts in pools, hot tubs or the shower," removing your lenses at the first sign of discomfort. And don't use saliva to clean your lenses, as Boparai warns this makes you more vulnerable to infection.
What about colored contacts and costume contacts?
Cosmetic contacts, especially non-prescription costume lenses, are dangerous to your eyes and the American Academy of Ophthalmology warns against wearing any contact lenses not prescribed to you by a medical professional. In fact, it's against the law to sell contact lenses without a prescription in the United States because of the risk of eye infections or permanent eye damage from poorly fitting or poorly manufactured lenses, which can damage wearers' eyes.
There are prescription cosmetic lenses on the market, mostly used to hide eye problems present from birth, but those need to be made specifically for the wearer's eyes, and they'll come with guidance from your eye doctor as to how long you should wear them and when they'll need replacing.
When to contact an eye doctor if you wear contact lenses
The AAO says that patients who are at low risk for ocular disease should get an eye exam at least every two years until the age of 64, unless their doctor recommends more frequent exams. After the age of 65, annual eye exams are the standard.
However, even if you're not high risk, you should see your eye doctor "as soon as possible if you experience eye pain, persistent redness or swelling, intolerance or discomfort with your lenses, sudden blurry vision, unusual discharge, excessive tearing and/or sensitivity to light," Agarwal said, adding that you should remove your lenses and not wear them again until your doctor gives you the go-ahead.
Vision changes also call for another visit to the eye doctor, says Boparai. He emphasizes that if you have uncomfortable symptoms or vision loss, "Your eye doctor will help guide management to keep your eyes comfortable and clear."
The bottom line
When in doubt, don't overwear your contact lenses. You should throw them out as soon as they expire, start to hurt your eyes or appear damaged. Wearing lenses improperly isn't just uncomfortable -- it can also lead to serious infections. Don't be afraid to call your eye doctor if something seems wrong.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
31 minutes ago
- Medscape
AI Is the New Dr Google — Across the Globe
Patients arriving at appointments with researched information is not new, but artificial intelligence (AI) tools such as ChatGPT are changing the dynamics. Their confident presentation can leave physicians feeling that their expertise is challenged. Kumara Raja Sundar, MD, a family medicine physician at Kaiser Permanente Burien Medical Center in Burien, Washington, highlighted this trend in a recent article published in JAMA . A patient visited Sundar's clinic reporting dizziness and described her symptoms with unusual precision: 'It's not vertigo, but more like a presyncope feeling.' She then suggested that the tilt table test might be useful for diagnosis. Occasionally, patient questions reveal subtle familiarity with medical jargon. This may indicate that they either have relevant training or have studied the subject extensively. Curious, Sundar asked if she worked in the healthcare sector. She replied that she had consulted ChatGPT, which recommended the tilt table test. For years, patients have brought newspaper clippings, internet research, and advice from friends and relatives to consultations. Suggestions shared in WhatsApp groups have become a regular part of clinical discussions. Sundar noted that this particular encounter was different. The patient's tone and level of detail conveyed competence, and the confidence with which she presented the information subtly challenged his clinical judgment and treatment plans. Clinical Practice It is not surprising that large language models (LLMs), such as ChatGPT, are appealing. Recent studies have confirmed their remarkable strengths in logical reasoning and interpersonal communication. However, a direct comparison between LLMs and physicians is unfair. Clinicians often face immense pressure, including constrained consultation times, overflowing inboxes, and a healthcare system that demands productivity and efficiency. Even skilled professionals struggle to perform optimally under adverse conditions. In contrast, generative AI is functionally limitless. This imbalance creates an unrealistic benchmark; however, this is today's reality. Patients want clear answers; more importantly, they want to feel heard, understood, and reassured. Patients value accurate information but also want to feel recognized, reassured, and heard. 'Unfortunately, under the weight of competing demands, which is what often slips for me not just because of systemic constraints but also because I am merely human,' Sundar wrote. Despite the capabilities of generative AI, patients still visit doctors. Though these tools deliver confidently worded suggestions, they inevitably conclude: 'Consult a healthcare professional.' The ultimate responsibility for liability, diagnostics, prescriptions, and sick notes remains with physicians. Patient Interaction In practice, this means dealing with requests, such as a tilt table test for intermittent vertigo, a procedure that is not uncommon but often inappropriate. 'I find myself explaining concepts such as overdiagnosis, false positives, or other risks of unnecessary testing. At best, the patient understands the ideas, which may not resonate when one is experiencing symptoms. At worst, I sound dismissive. There is no function that tells ChatGPT that clinicians lack routine access to tilt-table testing or that echocardiogram appointments are delayed because of staff shortages. I have to carry those constraints into the examination room while still trying to preserve trust,' Sundar emphasized in his article. When I speak with medical students, I notice a different kind of paternalism creeping in. And I have caught it in my inner monologue, even if I do not say it aloud. The old line, 'They probably WebMD'd it and think they have cancer,' has morphed into the newer, just-as-dismissive line, 'They probably ChatGPT'd it and are going to tell us what to order.' It often reflects defensiveness from clinicians rather than genuine engagement and carries an implicit message: We still know the best. 'It is an attitude that risks eroding sacred and fragile trust between clinicians and patients. It reinforces the feeling that we are not 'in it' with our patients and are truly gatekeeping rather than partnering. Ironically, that is often why I hear patients turn to LLMs in the first place,' Sundar concluded . Patient Advocacy One patient said plainly, 'This is how I can advocate for myself better.' The word 'advocate' struck Sundar, capturing the effort required to persuade someone with more authority. Although clinicians still control access to tests, referrals, and treatment plans, the term conveys a sense of preparing for a fight. When patients feel unheard, gathering knowledge becomes a strategy to be taken seriously. In such situations, the usual approach of explaining false-positive test results, overdiagnosis, and test characteristics is often ineffective. From the patient's perspective, this sounds more like, 'I still know more than you, no matter what tool you used, and I'm going to overwhelm you with things you don't understand.' Physician Role The role of physicians is constantly evolving. The transition from physician-as-authority to physician-as-advisor is intensifying. Patients increasingly present with expectations shaped by nonevidence-based sources, often misaligned with the clinical reality. As Sundar observed, 'They arm themselves with knowledge to be heard.' This necessitates a professional duty to respond with understanding rather than resistance. His approach centers on emotional acknowledgment before clinical discussion: 'I say, 'We'll discuss diagnostic options together. But first, I want to express my condolences. I can hardly imagine how you feel. I want to tackle this with you and develop a plan.'' He emphasized, 'This acknowledgment was the real door opener.' Global Trend What began as a US trend observed by Sundar has now spread worldwide, with patients increasingly arriving at consultations armed with medical knowledge from tools like ChatGPT rather than just 'Dr Google.' Clinicians across health systems have reported that digitally informed patients now comprise the majority. In a forum discussion, physicians from various disciplines shared their experiences, highlighting how previously informed patients are now the norm. Inquiries often focus on specific laboratory values, particularly vitamin D or hormone tests. In gynecologic consultations, Internet research on menstrual disorders has become a routine part of patient interactions, with an overwhelming range of answers available online. ' Chanice ,' a Coliquio user who's a gynecologist, shared, 'The answers range from, 'It's normal; it can happen' to 'You won't live long.'' 'It's also common to Google medication side effects, and usually, women end up experiencing pretty much every side effect, even though they didn't have them before.' How should doctors respond to this trend? Opinions are clear: openness, education, and transparency are essential and ideally delivered in a structured manner. 'Get the patients on board; educate them. In writing! Each and every one of them. Once it's put into words, it's no longer a job. Invest time in educating patients to correct misleading promises made by health insurance companies and politicians,' commented another user, Jörg Christian Nast, a specialist in gynecology and obstetrics. The presence of digitally informed patients is increasingly seen not only as a challenge but also as an opportunity. Conversations with these patients can be constructive, but they can also generate unrealistic demands or heated debates. Thus, a professional, calm, and explanatory approach remains crucial, and at times, a dose of humor can help. Another user who specializes in internal medicine added, 'The term 'online consultation' takes on a whole new meaning.' The full forum discussion, 'The Most Frequently Asked 'Dr. Google' Questions,' can be found here. Find out what young physicians think about AI and the evolving doctor-patient relationship in our interview with Christian Becker, MD, MHBA, University Medical Center Göttingen, Göttingen, Germany, and a spokesperson for the Young German Society for Internal Medicine. Read the full interview here.


Medscape
an hour ago
- Medscape
Cefazolin Best for Cesarean Infection Prevention
TOPLINE: In planned cesarean deliveries, cefazolin demonstrates superior infection prevention compared with clindamycin plus gentamicin, with significantly lower rates of inpatient antibiotic use (5.9% vs 15.2%) and readmissions (1.8% vs 3.8%). METHODOLOGY: Researchers conducted a retrospective cohort study at a university-affiliated tertiary medical center between 2012 and 2023, including women undergoing planned cesarean delivery. Analysis included 11,246 eligible women with 10,588 receiving cefazolin (standard regimen) and 658 receiving clindamycin plus gentamicin (alternative regimen) because of severe penicillin or cephalosporin allergies. Prophylactic antibiotics were administered within 30 minutes before incision with cefazolin dosing at 2 g (3 g for women weighing ≥ 120 kg) and the alternative regimen consisting of clindamycin 600 mg plus gentamycin 5 mg/kg. Primary outcome measures included the need for inpatient antibiotic treatment, and secondary outcomes included readmission for obstetric or gynecologic complications. TAKEAWAY: Infectious complications occurred less frequently in the cefazolin group with inpatient antibiotic treatment rates of 5.9% compared with 15.2% in the clindamycin plus gentamicin group (P < .001). Readmission rates were significantly lower in the cefazolin group at 1.8% vs 3.8% in the alternative regimen group (P = .001). Multivariate analysis revealed the alternative regimen group had higher odds of requiring inpatient antibiotics (adjusted odds ratio [aOR], 2.1; 95% CI, 1.54-2.80; P < .001) and readmission (aOR, 1.95; 95% CI, 1.19-3.18; P = .008). IN PRACTICE: 'Cefazolin may be more effective than clindamycin plus gentamicin in preventing infectious complications after planned cesarean delivery. This study emphasizes the importance of careful assessment of β-lactam allergies to guide optimal antibiotic choices. For women allergic to standard regimens, alternative strategies should be considered to reduce postoperative infections and complications,' the authors of the study wrote. SOURCE: This study was led by Daniel Gabbai, MD, MPH, Lis Hospital for Women's Health, Tel Aviv Sourasky Medical Center in Tel Aviv, Israel, and published in O&G Open. LIMITATIONS: According to the authors, this study used indirect indicators of infectious complications rather than direct diagnoses of endometritis or surgical site infections. The retrospective design introduced potential selection bias, particularly due to missing data on prophylactic antibiotic use in some patients. The researchers noted that while major confounders were controlled for, unmeasured factors might have influenced the observed differences between antibiotic groups. Additionally, data on prenatal antibiotic use were not consistently available, and the 12-year study period at a single tertiary care center may limit the generalizability of findings to other institutions with different patient populations and care practices. DISCLOSURES: The authors reported no relevant conflicts of interest. This study was approved by the Tel Aviv Sourasky Medical Center Institutional Review Board (No. TLV-0284-08, July 10, 2024). This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Medscape
2 hours ago
- Medscape
FDA Warns of Future Action on Animal-Derived Thyroid Drugs
The top US regulator of medicines this week said he wants to officially approve an animal-derived thyroid drug, seemingly addressing concerns sparked by a press release from his own agency. On August 6, the FDA sent letters to manufacturers, importers, and distributors of animal-derived thyroid medications, stating that the agency 'intends to take action against marketed unapproved animal-derived thyroid (ADT) products (sometimes described as desiccated thyroid extract [DTE] products).' 'Due to their complex biological origin, these medications contain many compounds that are uncharacterized for safety and effectiveness,' the FDA said, noting that it could take as long as '12 months to safely transition patients to an FDA-approved thyroid hormone replacement product.' 'FDA is not taking immediate action against manufacturers who make unapproved animal-derived thyroid medication to give patients time to transition to an FDA-approved medication to treat their hypothyroidism,' the agency said. Following this announcement, in an August 13 post on his verified account on X, FDA Commissioner Marty Makary wrote that his agency 'is committed to pursuing the first-ever approval of desiccated thyroid extract, pending results of the ongoing clinical trials' and 'will in the meantime ensure access for all Americans,' without specifying what kind of thyroid medications would be available. The X post came after considerable social media backlash to the FDA's plans to shift patients toward synthetic thyroid medications and away from animal-derived versions. FDA-approved laboratory-made, or synthetic, thyroid medications currently dominate the US market. About 22 million people received prescriptions for levothyroxine through outpatient retail pharmacies in 2024 compared to an estimated 1.5 million patients who received prescriptions for animal-derived versions, the FDA said. Marketed under names such as Armour Thyroid, NP Thyroid, Nature-Thyroid, and Natural Thyroid, these medications are produced from dried, ground animal thyroid glands, usually those of pigs. Complex History The FDA has had a long and challenging history with regulating thyroid medicines. These drugs were first sold in the US well before federal laws gave the FDA the regulatory powers it now has, Antonio Bianco, MD, PhD, of the University of Texas Medical Branch, Galveston, Texas, and former president of the American Thyroid Association, told Medscape Medical News . 'Because they existed before the FDA, their regulatory pathway is really complicated,' Bianco said. In 1965, four of every five prescriptions for thyroid hormone were for natural thyroid preparations, as pharmacologic authorities confirmed that these were highly effective, well-absorbed, and produced clinically predictable outcomes, wrote Roselyn Cristelle Mateo-Collado, MD, of Rush University, Chicago, and James V. Hennessey, MD, of Harvard Medical School, Boston, in a 2019 review in Endocrine . But reports of patients not responding to desiccated thyroid triggered concerns about inconsistencies in the potency of these tablets, they added. Over time, a newer synthetic version, levothyroxine, became more widely used, even with concerns arising as well about inconsistent potency. Between 1987 and 1994, the FDA received 58 adverse experience reports associated with the potency of orally administered levothyroxine products. In 1997, the FDA mandated that any company wishing to market levothyroxine must first secure agency approval. In 2002, Abbott Laboratories received approval to keep selling its levothyroxine drug, Synthroid, which had been on the market for more than 40 years and was being taken by about 8 million people in the US, Abbott said at the time. In 2013, Abbott spun off its drug business as AbbVie. AbbVie now markets both Synthroid and Armour Thyroid, a desiccated thyroid drug. What's Next? In his X post, the FDA chief Makary did not mention any specific studies that he expects to lead to approval of a desiccated thyroid drug. AbbVie is sponsoring a phase 2/3 study examining the safety of its Armour Thyroid against the synthetic thyroid medicine, according to the website. AbbVie declined to comment on this story. Other companies also are working on research studies for their animal-derived thyroid drugs, so the FDA's August 7 announcement came as an unwelcome surprise for many people, Bianco said. Makary's X post this week likely was meant to respond to pushback from supporters of the animal-derived drugs, he added, noting that the commissioner's tone may signal that the agency is 'correcting course' and minimizing the impact of the agency's announcement. 'The manufacturers are working very hard' on large-scale trials, Bianco said. 'They require money and time to be done properly, and I think that's what the FDA should be stimulating.' Bianco reported being a consultant for AbbVie, Acella, Aligos, and Synthonics.